Clinical Trial Update: Glycemic Optimization Treatment Study [Phase 4]

View source ↗

Summary

Phase 4 trial update on a glycemic optimization treatment for Type 2 diabetes, sponsored by Sanofi. The study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Snippet

Sponsor: Sanofi | Conditions: Diabetes Mellitus, Type 2 | Phase 4 | Status: COMPLETED